Cases & Deals

  • Home
  • Practices
  • CARMAT takes out €50 million equity line with Kepler Cheuvreux

Share

CARMAT takes out €50 million equity line with Kepler Cheuvreux

January 2015

Client(s) CARMAT SA

Jones Day advised CARMAT SA, a developer of heart prosthesis, in connection with a €50 million (US$57.7 million) equity line with Kepler Cheuvreux.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.